Status: Recruiting
Phase 2 Clinical Trial of CartiLife® in the United States
To evaluate the safety and efficacy of implanting pellet-type extracellular matrix-associated autologous chondrocytes (CartiLife®) obtained by cultivating costal chondrocytes of the subject with articular cartilage defects of the knee as a result of trauma or degeneration.
Participants needed: 25
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Biosolution Co., Ltd.Updated: Aug 28, 2023Locations: 5
Eligibility criteria
Male or female subjects aged over 18 at the time of signing the Informed Consent... [+11]
Subject who has inflammatory articular diseases such as rheumatoid arthritis or... [+22]